retatrutide expanded access program eli lilly Democratic lawmakers are pressing the Trump administration to disclose who received special to Lilly's investigational obesity drug retatrutide. Sen. Maggie Hassan (D-N.H.) sent a letter to HHS Secretary Robert F ADA 2026: Lilly Sees Retatrutide

US$ 23.51

★★★★★ 4.7 (20 reviews)

US$ 26.79

★★★★★ 5.0 (19 reviews)

US$ 26.70

★★★★★ 4.2 (9 reviews)

US$ 23.42

★★★★★ 4.5 (26 reviews)

US$ 25.22

★★★★★ 4.6 (5 reviews)

US$ 25.80

★★★★★ 4.9 (30 reviews)

US$ 29.95

★★★★★ 4.7 (15 reviews)

US$ 21.48

★★★★★ 4.2 (23 reviews)

US$ 20.59

★★★★★ 4.3 (20 reviews)

US$ 23.89

★★★★★ 4.6 (29 reviews)

US$ 23.37

★★★★★ 4.1 (11 reviews)

US$ 21.95

★★★★★ 4.6 (18 reviews)

US$ 26.01

★★★★★ 4.7 (26 reviews)

US$ 25.58

★★★★★ 4.6 (13 reviews)

US$ 28.90

★★★★★ 4.1 (26 reviews)

US$ 23.63

★★★★★ 4.9 (14 reviews)

US$ 24.52

★★★★★ 4.1 (25 reviews)

US$ 20.38

★★★★★ 4.3 (30 reviews)

US$ 28.20

★★★★★ 4.3 (25 reviews)

US$ 23.12

★★★★★ 4.7 (16 reviews)